12/11/2012
https://www.congress.gov...
"I am not one of those who advocate for regulations for regulations' sake."
"the intellectual property questions in the biopharmaceutical field are incredibly important."
"For those who like it and for those who do not like it, it is the law of the land."
"I think it is time, maybe, to dust off what is called Section 301."